Amylyx Pharmaceuticals Inc.
Doing business as Amylyx
- UEI
- Y5H6VQL1KHQ1
- CAGE
- 7ZTZ1
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- amylyx.com
- Founded
- 2013
- Employees
- 251-1K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Relyvrio - pharmaceutical | Veterans Integrated Service Network 20 | $0 | |
| Sodium phenylbutyrate 3GM taurursodiol 1GM PKT pwdr oral relyvrio 56 | Veterans Integrated Service Network 21 | $93,600 | |
| Relyvrio | Veterans Integrated Service Network 21 | $56,160 | |
| Relyvrio | Veterans Integrated Service Network 21 | $46,800 | |
| Relyvrio | Veterans Integrated Service Network 20 | $110,015 |
About Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc., doing business as Amylyx, is a biopharmaceutical company that provides pharmaceutical products to the U.S. federal government, primarily through the Department of Veterans Affairs (VA). The company specializes in developing treatments for neurodegenerative diseases, with a focus on amyotrophic lateral sclerosis (ALS). Amylyx's primary product supplied to the government is RELYVRIO, an FDA-approved treatment for ALS containing sodium phenylbutyrate and taurursodiol. As a self-certified small disadvantaged business, Amylyx has secured multiple contract vehicles with the VA to facilitate the distribution of its pharmaceutical products to veterans across the country.
The majority of Amylyx's federal contract awards are for the provision of RELYVRIO to various Veterans Integrated Service Networks (VISNs) within the Veterans Health Administration (VHA). These awards are typically firm-fixed-price delivery orders ranging from approximately $10,000 to $350,000, with performance periods generally spanning a few months. The place of performance for these contracts is usually Cambridge, Massachusetts, where Amylyx is headquartered. The company has received multiple awards from VISN 20 and VISN 21, indicating a strong presence in supplying ALS treatment to VA medical facilities in the western United States. No subcontractors or set-aside designations were identified in the provided contract information, suggesting that Amylyx directly fulfills these orders as a prime contractor.
Amylyx holds several significant Indefinite Delivery Vehicles (IDVs) with the federal government. The company was awarded a Federal Supply Schedule (FSS) contract (36F79723D0136) by the VA National Acquisition Center, with a ceiling value of $225,000 and a performance period through May 31, 2028. This multiple-award contract allows for the procurement of drugs, pharmaceuticals, and hematology-related products. Additionally, Amylyx has two Blanket Purchase Agreements (BPAs) with the VA. The first (36E79723A0017) has a ceiling value of $50,000 and runs through June 11, 2024, specifically for the procurement of RELYVRIO. The second BPA (36E79723A0009), also valued at $50,000, expired on June 27, 2023. These contract vehicles enable VA facilities nationwide to efficiently order RELYVRIO and other Amylyx products as needed. The company also held an interim agreement (36F79723D010E) under FSS Schedule 65 I B for drugs and pharmaceuticals, which had a ceiling value of $25,000 and expired on May 31, 2023. These IDVs demonstrate Amylyx's established relationship with the VA and its commitment to providing ALS treatment to veterans through various contractual mechanisms.
Quick answers
What is Amylyx Pharmaceuticals Inc.'s UEI?
Amylyx Pharmaceuticals Inc.'s Unique Entity ID (UEI) in SAM.gov is Y5H6VQL1KHQ1.
What is Amylyx Pharmaceuticals Inc.'s CAGE code?
Amylyx Pharmaceuticals Inc.'s CAGE code is 7ZTZ1.
What is Amylyx Pharmaceuticals Inc.'s primary NAICS code?
Amylyx Pharmaceuticals Inc.'s primary NAICS code is 424210 (Drugs and Druggists' Sundries Merchant Wholesalers).
Is Amylyx Pharmaceuticals Inc. registered in SAM.gov?
Amylyx Pharmaceuticals Inc.'s SAM.gov registration expired on October 8, 2024.
What is Amylyx Pharmaceuticals Inc.'s most recent federal award?
Amylyx Pharmaceuticals Inc.'s most recent federal contract award is Relyvrio - pharmaceutical (36C26024F0268), from Veterans Integrated Service Network 20, on April 1, 2024.
On GovTribe
See Amylyx Pharmaceuticals Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors